Birdwatch Note
2024-04-07 00:17:35 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
ケンブリッジ大が接種者がAIDSと報告という昨年12月の噂話に関しては下記で出典と検証がされており、 https://leadstories.com/hoax-alert/2023/12/fact-check-cambridge-scientists-did-not-admit-25-percent-of-vaccinated-people-now-have-vaids.html 新型コロナワクチンで意図せぬタンパクが生成される事があるという研究が、なぜかAIDSになる話になったという噂です。 実際には、勿論この研究ではそうした事は報告されておらず、研究チームは、接種を受けた研究対象の21人の患者のうち3分の1で意図しない免疫反応が発生したが、これらの新型コロナウイルスワクチンについて入手可能な広範な安全性データと一致して、悪影響はなかったことが判明したとリリースしており、著者らはワクチンの有効性と安全性を支持しております。
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1776481966692634634
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1776766232991256789
- noteId - 1776766232991256789
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1712449055323
- tweetId - 1776481966692634634
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- ケンブリッジ大が接種者がAIDSと報告という昨年12月の噂話に関しては下記で出典と検証がされており、 https://leadstories.com/hoax-alert/2023/12/fact-check-cambridge-scientists-did-not-admit-25-percent-of-vaccinated-people-now-have-vaids.html 新型コロナワクチンで意図せぬタンパクが生成される事があるという研究が、なぜかAIDSになる話になったという噂です。 実際には、勿論この研究ではそうした事は報告されておらず、研究チームは、接種を受けた研究対象の21人の患者のうち3分の1で意図しない免疫反応が発生したが、これらの新型コロナウイルスワクチンについて入手可能な広範な安全性データと一致して、悪影響はなかったことが判明したとリリースしており、著者らはワクチンの有効性と安全性を支持しております。
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-04-07 00:17:35 UTC (1712449055323) |
2024-04-07 06:10:46 UTC (1712470246138) |
CURRENTLY_RATED_HELPFUL | 2024-04-08 02:51:43 UTC (1712544703825) |
CURRENTLY_RATED_HELPFUL | 2024-04-07 06:10:46 UTC (1712470246138) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-04-06 20:15:42 -0500 | Rating Details | |
2024-04-06 20:05:12 -0500 | Rating Details | |
2024-04-06 19:51:05 -0500 | Rating Details | |
2024-04-06 19:49:50 -0500 | Rating Details | |
2024-04-06 19:49:43 -0500 | Rating Details | |
2024-04-06 19:45:22 -0500 | Rating Details | |
2024-04-06 19:42:15 -0500 | Rating Details | |
2024-04-06 19:39:55 -0500 | Rating Details | |
2024-04-06 19:37:07 -0500 | Rating Details | |
2024-04-06 19:35:43 -0500 | Rating Details | |
2024-04-06 19:26:15 -0500 | Rating Details | |
2024-04-07 18:54:29 -0500 | Rating Details | |
2024-04-07 18:38:38 -0500 | Rating Details | |
2024-04-07 13:17:18 -0500 | Rating Details | |
2024-04-07 10:14:20 -0500 | Rating Details | |
2024-04-07 09:38:13 -0500 | Rating Details | |
2024-04-07 08:31:29 -0500 | Rating Details | |
2024-04-07 08:11:23 -0500 | Rating Details | |
2024-04-07 08:08:51 -0500 | Rating Details | |
2024-04-07 08:06:41 -0500 | Rating Details | |
2024-04-07 07:33:02 -0500 | Rating Details | |
2024-04-07 07:30:31 -0500 | Rating Details | |
2024-04-07 07:28:37 -0500 | Rating Details | |
2024-04-07 07:27:45 -0500 | Rating Details | |
2024-04-07 07:25:16 -0500 | Rating Details | |
2024-04-07 06:06:44 -0500 | Rating Details | |
2024-04-07 00:12:22 -0500 | Rating Details | |
2024-04-06 23:02:47 -0500 | Rating Details | |
2024-04-06 22:47:40 -0500 | Rating Details | |
2024-04-06 22:46:50 -0500 | Rating Details | |
2024-04-06 21:47:04 -0500 | Rating Details | |
2024-04-06 21:22:51 -0500 | Rating Details | |
2024-04-06 21:10:37 -0500 | Rating Details | |
2024-04-06 21:05:44 -0500 | Rating Details | |
2024-04-08 08:58:52 -0500 | Rating Details | |
2024-04-07 21:06:25 -0500 | Rating Details | |
2024-04-09 17:15:03 -0500 | Rating Details | |
2024-04-07 07:29:38 -0500 | Rating Details | |
2024-04-13 01:32:01 -0500 | Rating Details | |
2024-04-13 05:36:35 -0500 | Rating Details | |
2024-04-13 01:50:55 -0500 | Rating Details | |
2024-04-13 01:43:13 -0500 | Rating Details | |
2024-04-09 02:15:20 -0500 | Rating Details | |
2024-04-08 15:41:42 -0500 | Rating Details | |
2024-04-07 10:58:18 -0500 | Rating Details | |
2024-04-07 10:37:06 -0500 | Rating Details | |
2024-04-07 09:02:17 -0500 | Rating Details | |
2024-04-07 09:00:20 -0500 | Rating Details | |
2024-04-07 08:31:59 -0500 | Rating Details | |
2024-04-07 08:12:43 -0500 | Rating Details | |
2024-04-07 08:04:04 -0500 | Rating Details | |
2024-04-07 08:02:11 -0500 | Rating Details | |
2024-04-07 07:52:29 -0500 | Rating Details | |
2024-04-07 07:40:38 -0500 | Rating Details | |
2024-04-07 07:37:13 -0500 | Rating Details | |
2024-04-07 07:29:52 -0500 | Rating Details | |
2024-04-07 07:23:37 -0500 | Rating Details | |
2024-04-06 23:44:01 -0500 | Rating Details | |
2024-04-06 23:43:31 -0500 | Rating Details | |
2024-04-06 22:16:15 -0500 | Rating Details | |
2024-04-06 21:06:19 -0500 | Rating Details | |
2024-04-06 21:04:19 -0500 | Rating Details | |
2024-04-06 20:41:43 -0500 | Rating Details | |
2024-04-06 20:22:34 -0500 | Rating Details | |
2024-04-06 20:08:16 -0500 | Rating Details | |
2024-04-06 19:57:25 -0500 | Rating Details | |
2024-04-06 19:53:19 -0500 | Rating Details | |
2024-04-06 19:47:23 -0500 | Rating Details | |
2024-04-06 19:44:44 -0500 | Rating Details | |
2024-04-06 19:36:18 -0500 | Rating Details | |
2024-04-06 19:32:09 -0500 | Rating Details | |
2024-04-12 17:16:44 -0500 | Rating Details | |
2024-04-09 19:03:13 -0500 | Rating Details | |
2024-04-09 08:36:08 -0500 | Rating Details |